HUP9904243A3 - Method for inhibiting the expression of fas - Google Patents

Method for inhibiting the expression of fas

Info

Publication number
HUP9904243A3
HUP9904243A3 HU9904243A HUP9904243A HUP9904243A3 HU P9904243 A3 HUP9904243 A3 HU P9904243A3 HU 9904243 A HU9904243 A HU 9904243A HU P9904243 A HUP9904243 A HU P9904243A HU P9904243 A3 HUP9904243 A3 HU P9904243A3
Authority
HU
Hungary
Prior art keywords
fas
inhibiting
expression
Prior art date
Application number
HU9904243A
Other languages
English (en)
Original Assignee
Boehringer Mannheim Pharm Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Pharm Corp filed Critical Boehringer Mannheim Pharm Corp
Publication of HUP9904243A2 publication Critical patent/HUP9904243A2/hu
Publication of HUP9904243A3 publication Critical patent/HUP9904243A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Separation By Low-Temperature Treatments (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Fats And Perfumes (AREA)
HU9904243A 1996-08-23 1997-08-22 Method for inhibiting the expression of fas HUP9904243A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2448696P 1996-08-23 1996-08-23

Publications (2)

Publication Number Publication Date
HUP9904243A2 HUP9904243A2 (hu) 2000-05-28
HUP9904243A3 true HUP9904243A3 (en) 2001-09-28

Family

ID=21820837

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9904243A HUP9904243A3 (en) 1996-08-23 1997-08-22 Method for inhibiting the expression of fas

Country Status (17)

Country Link
US (1) US6096777A (hu)
EP (1) EP0924985A4 (hu)
JP (1) JP2001504804A (hu)
KR (1) KR20000068322A (hu)
CN (1) CN1233150A (hu)
AU (1) AU4083097A (hu)
BR (1) BR9711228A (hu)
CA (1) CA2264178A1 (hu)
CZ (1) CZ59199A3 (hu)
HU (1) HUP9904243A3 (hu)
IL (1) IL128613A (hu)
NO (1) NO990792L (hu)
NZ (1) NZ334307A (hu)
PL (1) PL331766A1 (hu)
TR (1) TR199900370T2 (hu)
WO (1) WO1998007321A1 (hu)
ZA (1) ZA977565B (hu)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
US20050148779A1 (en) * 2002-04-30 2005-07-07 Wei Chen Carvedilol monocitrate monohydrate
CA2492084A1 (en) * 2002-06-27 2004-01-08 Sb Pharmco Puerto Rico Inc. Carvedilol hydobromide
CN1678305A (zh) * 2002-06-27 2005-10-05 Sb药物波多黎各公司 卡维地洛磷酸盐和/或其溶剂合物和/或相应组合物和/或治疗方法
US6632832B1 (en) 2002-09-10 2003-10-14 Dabur Research Foundation Anti-cancer activity of carvedilol and its isomers
AU2002336473A1 (en) * 2002-09-10 2004-04-30 Dabur Research Foundation Anti-cancer activity of carvedilol and its isomers
WO2005051383A1 (en) * 2003-11-25 2005-06-09 Sb Pharmco Puerto Rico Inc. Carvedilol salts, corresponding compositions, methods of delivery and/or treatment
US20050169994A1 (en) * 2003-11-25 2005-08-04 Burke Matthew D. Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
US20050175695A1 (en) * 2003-11-25 2005-08-11 Catherine Castan Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
ZA200803226B (en) 2005-10-13 2009-11-25 Orchid Res Lab Ltd Heterocyclic Compounds as Pstat3/IL-6 Inhibitors
JP2012051804A (ja) * 2008-12-26 2012-03-15 Kyoto Univ Ｅｇ５阻害剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2815926A1 (de) * 1978-04-13 1979-10-18 Boehringer Mannheim Gmbh Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US5393772A (en) * 1993-11-24 1995-02-28 Boehringer Mannheim Pharmaceuticals Corporation Use of, and method of treatment using, hydroxycarbazole compounds for inhibition of smooth muscle migration and proliferation

Also Published As

Publication number Publication date
EP0924985A4 (en) 2000-12-06
CZ59199A3 (cs) 1999-08-11
TR199900370T2 (xx) 1999-05-21
NZ334307A (en) 2000-11-24
JP2001504804A (ja) 2001-04-10
NO990792D0 (no) 1999-02-19
HUP9904243A2 (hu) 2000-05-28
PL331766A1 (en) 1999-08-02
WO1998007321A1 (en) 1998-02-26
NO990792L (no) 1999-04-15
CN1233150A (zh) 1999-10-27
KR20000068322A (ko) 2000-11-25
AU4083097A (en) 1998-03-06
IL128613A0 (en) 2000-01-31
BR9711228A (pt) 2000-01-11
US6096777A (en) 2000-08-01
IL128613A (en) 2004-07-25
EP0924985A1 (en) 1999-06-30
CA2264178A1 (en) 1998-02-26
ZA977565B (en) 1999-02-17

Similar Documents

Publication Publication Date Title
HUP0004592A3 (en) Compounds and methods for the inhibition of the expression of vcam-1
ZA98643B (en) Method for inhibiting the growth of cancers
IL120262A0 (en) Method of increasing testosterone
IL129759A0 (en) Process for the preparation of benzyl-ethers
HUP0101896A3 (en) Method and system for the application of lacquer
HUP0003114A3 (en) Method for the preparation of carbamates
PL318452A1 (en) Method of obtaining peroxyperfluoropolyoxyalkylenes
ZA977565B (en) Method for inhibiting the expression of fas
PL330400A1 (en) Method of obtaining azacyclohexapeptides
IL119612A0 (en) Method for the production of khalas
ZA981885B (en) Method for the preparation of alpha-bromo-lactam derivatives
EP0669361A3 (en) Process for the preparation of polyheterosiloxanes.
PL332077A1 (en) Method of obtaining omepraole
HUP9901029A3 (en) Method for the production of rdspa alfa1
PL313419A1 (en) Method of obtaining beta-naphtole
ZA984534B (en) Method for the preparation of carbamates
PL333977A1 (en) Method of obtaining benzisothiazolyn-3-ones
IL128026A0 (en) Process for the preparation of hexanitrohexa-azaisowurtzitanes
GB2330888B (en) Method for the synchronisation of at least two signals
PL317788A1 (en) Method of obtaining 3-isocyanate-propylsilane
PL332075A1 (en) Method of obtaining nizathidine
IL116759A0 (en) Process for the preparation of para-fluorophenol
EP0831156A4 (en) 3-ALCOXYMETHYLCEPHEMS PREPARATION PROCESS
PL301929A1 (en) Method of obtaining epichlorohydine
PL332208A1 (en) Method of obtaining benzzothiophenes